Management of recalled pacemakers and implantable cardioverter- defibrillators A decision analysis model

JAMA

Volumn 296, Issue 4, 2006, Pages 412-420

  Amin, Mitesh S ^a   Matchar, David B ^c,d   Wood, Mark A ^b   Ellenbogen, Kenneth A ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR RISK; CAROTID SINUS; CLINICAL FEATURE; CONTROLLED STUDY; DEFIBRILLATOR; DEMOGRAPHY; FOLLOW UP; HEALTH STATUS; HEART ARRHYTHMIA; HUMAN; HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MARKUP LANGUAGE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL INSTRUMENTATION; MORTALITY; PATIENT MONITORING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SUDDEN DEATH; SURVIVAL; TREATMENT FAILURE; TREATMENT INDICATION;

EID: 33746430581     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.4.412     Document Type: Article

References (32)

1. Maisel WH. Safety issues involving medical devices: implications of recent implantable cardioverter-defibrillator malfunctions. JAMA. 2005;294:955-958.
2. Maisel WH, Moynahan M, Zuckerman BD, et al. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA. 2006;295:1901-1906.
3. Maisel WH. Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA. 2006;295:1929-1934.
4. Auricchio A, Gropp M, Ludgate S, et al. European Heart Rhythm Association guidance document on cardiac rhythm management product performance. Europace. 2006;8:313-322.
5. Maisel WH. Physician management of pacemaker and implantable cardioverter-defibrillator advisories. Pacing Clin Electrophysiol. 2004;27:437-442.
6. Weinstein MC, Fineberg HV, Elstein AS, et al. Clinical Decision Analysis. Philadelphia, Pa: WB Saunders; 1980:131-166.
7. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13:322-338.
8. Wild DM, Fisher JD, Kim SG, Ferrick KJ, Gross JN, Palma EC. Pacemakers and implantable cardioverter defibrillators: device longevity is more important than smaller size: the patient's viewpoint. Pacing Clin Electrophysiol. 2004;27:1526-1529.
9. Gould PA, Krahn AD; Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardioverter- defibrillator replacement in response to device advisories. JAMA. 2006;295:1907-1911.
10. Thomas AC, Moser SA, Smutka ML, Wilson PA. Implantable defibrillation: eight years clinical experience. Pacing Clin Electrophysiol. 1988;11:2053-2058.
11. Smith PN, Vidaillet HJ, Hayes JJ, et al. Infection with nonthoracotomy implantable cardioverter defibrillators: can these be prevented? Pacing Clin Electrophysiol. 1998;21:42-55.
12. Mela T, McGovern BA, Garan H, et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter defibrillator implants. Am J Cardiol. 2001;88:750-753.
13. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. J Am Coll Cardiol. 1996;28:1278-1282.
14. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol. 2005;28:926-932.
15. Wiegand UK, LeJeune D, Boguschewski F, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/ anticoagulation therapy. Chest. 2004;126:1177-1186.
16. Zaim S, Connolly M, Roman-Gonzalez J, Walter P, Craver J, Jones E. Perioperative complications of cardioverter-defibrillator implantation: the Emory experience. Am J Med Sci. 1994;307:185-189.
17. Harcombe AA, Newell SA, Ludman PF, et al. Late complications following permanent pacemaker implantation or elective unit replacement. Heart. 1998;80:240-244.
18. Chauhan A, Grace AA, Newell SA, et al. Early complications after dual chamber versus single chamber pacemaker implantation. Pacing Clin Electrophysiol. 1994;17:2012-2015.
19. Ellenbogen KA, Hellkamp AS, Wilkoff BL, et al. Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol. 2003;92:740-741.
20. Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br Heart J. 1995;73:571-575.
21. Tobin K, Stewart J, Westveer D, Frumin H. Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol. 2000;85:774-776, A9.
22. Medtronic. Marquis Patient Management Information. Minneapolis, Minn: Medtronic; 2005.
23. Guidant Advisory Update: Contak Renewal & Contak Renewal 2, Models H135 and H155. Indianapolis, Ind: Guidant; 2005.
24. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implantable automatic defibrillator in human beings. N Engl J Med. 1980;303:322-324.
25. Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
26. Bristow MR, Saxon LA, Boehmer J, et al; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
27. Moss AJ, Zareba W, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
28. Bardy GH, Lee KL, Mark DB, et al; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
29. Kochanek KD, Murphy SL, Anderson RN, Scott C. Deaths: final data for 2002. Natl Vital Stat Rep. 2004;53:1-115.
30. Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JP. A convenient approximation of life expectancy (the "DEALE"), II: use in medical decision making. Am J Med. 1982;73:889-897.
31. Kay GN, Brinker JA, Kawanishi DT, et al. Risks of spontaneous injury and extraction of an active fixation pacemaker lead: report of the Accufix Multicenter Clinical Study and Worldwide Registry. Circulation. 1999;100:2344-2352.
32. Undavia M, Goldstein NE, Cohen P, et al. Impact of implantable cardioverter defibrillator recall on patients' anxiety, depression, and quality of life. Heart Rhythm. 2006;3:S177-S178.